Exploring patient preferences regarding the use of combination therapy with endothelin receptor antagonist (ERA) + phosphodiesterase-5 inhibitors (PDE5i)
探讨患者对内皮素受体拮抗剂(ERA)+磷酸二酯酶-5抑制剂(PDE5i)联合治疗的偏好
期刊:
影响因子:
doi:10.1016/j.jhlto.2025.100410
Kolaitis, Nicholas A; Kingman, Martha; Wilson, Melisa; Rendon, Gabriela Gomez; Lopez, David; Paoli, Carly J; Rahman, Mohammad; Martin, Ashley; McGarvey, November; Lee, Abraham; Mirza, Sana; Melendres-Groves, Lana